A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder
Becky S Wu1, Andrea H Weinberger, Enza Mancuso
1Schizophrenia Program, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada.
Journal of Dual Diagnosis
|September 11, 2012
Abstract
No abstract available in PubMed .


